Detalhe da pesquisa
1.
A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer.
Mol Cancer
; 22(1): 89, 2023 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248468
2.
Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.
J Neurooncol
; 165(1): 91-100, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37907716
3.
Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures.
Front Oncol
; 13: 1129627, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37114125
4.
Eukaryotic Translation Initiation Factor 4AI: A Potential Novel Target in Neuroblastoma.
Cells
; 10(2)2021 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33540613
5.
A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy.
Cancers (Basel)
; 13(6)2021 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33807050